Recombinant Human BMPR-IB

Recombinant Human BMPR-IB is used in research applications to study and manipulate bone morphogenetic protein (BMP) signaling, which is crucial for skeletal development, regeneration, and disease modeling. It serves as a high-affinity receptor for BMPs, enabling precise investigation of BMP-mediated cellular processes.

Key scientific applications and advantages:

• BMP Pathway Analysis: BMPR-IB (also known as ALK-6) is a type I receptor in the BMP signaling pathway. Using recombinant BMPR-IB allows researchers to dissect the molecular mechanisms of BMP-induced differentiation, proliferation, and migration, especially in mesenchymal stem cells and osteogenic lineages.

• Ligand Binding and Antagonism: Recombinant soluble BMPR-IB binds BMP-4 with high affinity and can act as a potent BMP-4 antagonist in vitro, making it valuable for studying ligand-receptor interactions and for blocking BMP signaling in experimental setups.

• Disease Modeling: BMPR-IB is implicated in rare bone diseases and common conditions such as fracture healing and spinal surgery. Recombinant BMPR-IB enables the development of new therapeutic strategies and the modeling of congenital or age-related bone disorders.

• Protein Engineering and Screening: Recombinant BMPR-IB can be used in high-throughput screening assays to identify BMP pathway modulators, test drug candidates, or characterize BMP receptor-ligand specificity.

• Cellular and Molecular Assays: It is suitable for biochemical assays (e.g., SDS-PAGE, ELISA), cell culture experiments, and structural studies to elucidate receptor function, downstream signaling, and protein-protein interactions.

Best practices:

• Use recombinant BMPR-IB in controlled in vitro systems to study BMP signaling dynamics.
• Employ it as a tool for competitive binding assays or as a decoy receptor to inhibit endogenous BMP activity.
• Combine with other BMP pathway components (ligands, antagonists, downstream effectors) for comprehensive pathway analysis.

Summary:
Recombinant Human BMPR-IB is a versatile reagent for investigating BMP signaling, bone biology, and related therapeutic applications, offering specificity, reproducibility, and scalability for advanced molecular and cellular research.

Yes, you can use recombinant human BMPR-IB as a standard for quantification or calibration in your ELISA assays, provided it is properly purified and quantified. This is a common and accepted practice in quantitative ELISA protocols for measuring BMPR-IB concentrations in biological samples.

Key considerations and best practices:

• Purity and Quantification: The recombinant BMPR-IB protein used as a standard should be highly purified, and its concentration must be accurately determined (e.g., by absorbance at 280 nm, BCA assay, or HPLC).
• Standard Curve Preparation: Prepare a dilution series of the recombinant BMPR-IB in the same buffer or matrix as your samples to generate a standard curve. This allows for accurate interpolation of sample concentrations.
• Matrix Matching: If your samples are in serum, plasma, or cell culture supernatant, ideally prepare your standards in the same matrix or use a suitable diluent to minimize matrix effects.
• Validation: Confirm that your ELISA detects both recombinant and native BMPR-IB with similar efficiency. Most commercial BMPR-IB ELISA kits are validated to recognize both natural and recombinant forms.
• Documentation: Follow the ELISA kit or assay protocol regarding standard preparation, as some kits may provide specific instructions or require standards with certain tags or formulations.

Supporting details from the literature and protocols:

• Recombinant proteins are routinely used as standards in quantitative ELISA assays for BMPR-IB and other proteins.
• Commercial BMPR-IB ELISA kits typically include recombinant human BMPR-IB as the standard, and their protocols can be adapted for custom assays.
• The standard curve is essential for quantification, and its accuracy depends on the quality and preparation of the recombinant standard.

Limitations and caveats:

• If your recombinant BMPR-IB differs in post-translational modifications or tags from the native protein, this could affect antibody recognition and quantification. Validate equivalence if possible.
• Ensure the recombinant standard is compatible with your assay’s detection antibodies and conditions.

Summary Table: Use of Recombinant BMPR-IB as ELISA Standard

In conclusion, recombinant human BMPR-IB is suitable as a standard for ELISA quantification, provided you follow best practices for preparation, validation, and assay setup.

Applications of Recombinant Human BMPR-IB in Published Research

Recombinant human BMPR-IB (also designated ALK-6) has been validated for several key applications in published research:

Biochemical and Protein Interaction Studies

Recombinant soluble BMPR-IB has been validated as a high-affinity ligand-binding protein, demonstrating the capacity to bind BMP-4 with high affinity in solution and function as a potent BMP-4 antagonist in vitro. This application is fundamental for understanding BMP signaling mechanisms and receptor-ligand interactions.

Analytical and Detection Applications

The protein has been validated for use in multiple analytical techniques including Western blotting, ELISA (enzyme-linked immunosorbent assay), immunoaffinity purification, and protein arrays. These applications enable researchers to quantify protein levels, detect BMPR-IB in complex biological samples, and characterize protein-protein interactions.

Cell Biology and Differentiation Studies

Research has extensively validated BMPR-IB's role in osteogenic differentiation of multipotent cells. Studies demonstrated a 700% increase in BMPR-IB expression during osteogenic differentiation of adipose-derived stem cells, with suppression of BMPR-IB levels via RNA interference significantly impairing bone formation capacity. This validation established BMPR-IB as a critical mediator of osteogenic lineage commitment.

Therapeutic Development

Recombinant BMPR-IB has been employed in therapeutic development research, particularly in studies investigating BMP signaling modulation for bone tissue engineering and regenerative medicine applications. The protein serves as a tool for understanding how BMP receptor signaling can be manipulated for clinical benefit.

These validated applications collectively establish recombinant human BMPR-IB as a versatile research tool for investigating BMP signaling pathways, receptor function, and therapeutic potential in bone regeneration.

To reconstitute and prepare Recombinant Human BMPR-IB protein for cell culture experiments, follow these general best practices, which are consistent with protocols for similar recombinant proteins:

1. Centrifuge the vial: Before opening, briefly centrifuge the lyophilized protein vial (10,000–14,000 × g for 20–30 seconds) to ensure all material is at the bottom and not lost when opening.

2. Choose the correct solvent: Most recombinant proteins are reconstituted in sterile distilled water or sterile PBS. However, always check the product datasheet or Certificate of Analysis (CoA) for any specific buffer recommendations, as some proteins require low pH or other specific conditions for optimal solubility.

3. Reconstitution concentration:

   • Reconstitute to a concentration between 0.1–1.0 mg/mL. For example, for 100 µg of protein, add 100–1000 µL of buffer.
   • Do not exceed 1 mg/mL to avoid solubility issues.

4. Gentle mixing:

   • Gently swirl or invert the vial to dissolve the protein. Do not vortex or shake vigorously, as this can denature the protein.
   • Allow the solution to sit at room temperature for 15–30 minutes with gentle agitation to ensure complete dissolution.

5. Carrier protein for dilution:

   • If you need to dilute the protein further (especially to low concentrations), use a buffer containing a carrier protein such as 0.1% BSA, 10% FBS, or 5% HSA to prevent adsorption and loss of activity.
   • For serum-free or animal experiments, use trehalose as a stabilizer instead of animal-derived proteins.

6. Aliquot and storage:

   • Aliquot the reconstituted protein to avoid repeated freeze-thaw cycles, which can degrade the protein.
   • For short-term storage (up to 1 week), keep at 2–8 °C.
   • For long-term storage, store aliquots at –20 °C to –80 °C, optionally with 5–50% glycerol as a cryoprotectant.

7. Handling and use:

   • Thaw aliquots on ice and avoid repeated freeze-thaw cycles.
   • Add the protein directly to your cell culture medium at the desired working concentration.

Summary Table: Key Steps for BMPR-IB Reconstitution

Note: Always consult the specific product datasheet or CoA for any unique requirements for your BMPR-IB preparation, as formulation and solubility can vary between constructs and manufacturers.

If your protein is expressed as inclusion bodies and requires refolding, additional steps involving denaturant removal and redox conditions are necessary, but for most commercially available soluble BMPR-IB, the above protocol is sufficient.